TEVA (NYSE: TEVA) director sold 16,195 shares for $532,330 per Form 144

Rhea-AI Filing Summary

TEVA Form 144 notice reports a proposed sale of Ordinary Shares and a recent sale by an affiliated holder. The filing lists a planned disposition through Citigroup Global Markets and records a sale by Matthew Shields of 16,195 shares for $532,329.65 on 06/03/2026. The securities are identified as Ordinary Shares with an associated identifier 9989.

Insights

Securities Compliance Counsel

Rule 144 notice records a reported sale and a proposed brokered disposition.

The filing lists Ordinary Shares to be sold via Citigroup Global Markets and classifies the sale reason as compensation and rollover in the transaction fields. The excerpt names Matthew Shields as the reporting holder with a recorded sale.

Cash‑flow treatment and any holding period or resale conditions are not shown in the excerpt; subsequent filings or broker confirmations would confirm settlement details and whether the notice met Rule 144 conditions.

Key Figures

Shares sold: 16,195 shares Proceeds: $532,329.65 Broker/Agent: Citigroup Global Markets +2 more

5 metrics

Shares sold 16,195 shares sale recorded on 06/03/2026

Proceeds $532,329.65 amount shown for Matthew Shields sale on 06/03/2026

Broker/Agent Citigroup Global Markets listed as broker at 390 Greenwich St, New York, NY

Security identifier 9989 identifier shown alongside Ordinary Shares in the filing header

Broker filing date 06/18/2026 date listed in the securities header for the broker/market entry

Key Terms

Form 144, Rollover, Compensation, Ordinary Shares

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rollover financial

"SHARES FROM ROLLOVER | TEVA PHARMACEUTICAL INDUSTRIES LIMITED"

Compensation financial

"06/03/2025 | SHARES FROM ROLLOVER | ... | COMPENSATION"

Ordinary Shares market

"ORDINARY SHARES | CITIGROUP GLOBAL MARKETS"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	9989	321546.91	1164426972	06/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	06/03/2025	SHARES FROM ROLLOVER	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			9989	06/18/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shields Matthew TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020	ORDINARY SHARES	06/03/2026	16195	532329.65

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TEVA's Form 144 disclose about recent insider sales?

The Form 144 discloses a sale by Matthew Shields of 16,195 Ordinary Shares for $532,329.65 on 06/03/2026. It reports the transaction type as related to compensation/rollover and lists Citigroup as the broker.

Who is listed as the broker for the proposed sale in the TEVA Form 144?

The filing lists Citigroup Global Markets at 390 Greenwich St, New York, NY, as the broker handling the proposed sale of Ordinary Shares. The filing shows an identifier 9989 associated with the securities.

Does the Form 144 indicate the number of shares planned for sale by the issuer or holder?

The excerpt records a completed sale of 16,195 shares by Matthew Shields and lists Ordinary Shares as the class to be sold; no separate aggregate offering amount for the issuer is provided in the excerpt.

What date is associated with the reported sale in TEVA's Form 144?

The reported sale by Matthew Shields is dated 06/03/2026 in the filing, with the proceeds shown as $532,329.65. The filing also includes a broker entry dated 06/18/2026 in the securities header.